KCTD7 antibody
Quick Overview for KCTD7 antibody (ABIN7245461)
Target
See all KCTD7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Characteristics
- Polyclonal Antibody
-
Purification
- Antigen affinity purification
-
Immunogen
- Synthetic peptide of human KCTD7
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:1000-1:5000, IHC 1:50-1:300, ELISA 1:5000-1:10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.56 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KCTD7 (Potassium Channel Tetramerisation Domain Containing 7 (KCTD7))
-
Alternative Name
- KCTD7
-
Background
- KCTD7 (Potassium Channel Tetramerization Domain Containing 7) is a Protein Coding gene. Diseases associated with KCTD7 include Epilepsy, Progressive Myoclonic 3, With Or Without Intracellular Inclusions and Cln14 Disease. Among its related pathways are Neuropathic Pain-Signaling in Dorsal Horn Neurons and Innate Immune System. An important paralog of this gene is KCTD14. This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.
-
Molecular Weight
-
Observed_MW: Refer to figures
Calculated_MW: 33 kDa
-
UniProt
- Q96MP8
Target
-